Security key
83422E204
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 15,014,401
- Total 13F value
- $80,763,090
- Share change
- +15,014,401
- SEC-reported price per share
- $5.38
- Number of holders
- 30
- Value change
- +$80,763,090
- Number of buys
- 30
- Shares outstanding
- 98,227,953
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
30
Top holders
10
SLDB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83422E204
Recent filing periods:
Ownership snapshot
Top reported holders of SLDB - Solid Biosciences Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
PERCEPTIVE ADVISORS LLC
13%
RA CAPITAL MANAGEMENT, L.P.
12%
Alyeska Investment Group, L.P.
8%
Bain Capital Life Sciences Invest...
7.9%
K2 PRINCIPAL FUND, L.P.
5.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
13%
|
$6,258,000
13,412,552 shares
|
— | 30 Sep 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
12%
|
$5,771,000
12,367,873 shares
|
— | 30 Sep 2022 |
| Alyeska Investment Group, L.P. |
13F
Company
|
8%
|
$3,738,000
8,102,223 shares
|
— | 30 Sep 2022 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
7.9%
|
$3,700,000
7,929,918 shares
|
— | 30 Sep 2022 |
| K2 PRINCIPAL FUND, L.P. |
13F
Company
|
5.5%
|
$2,478,000
5,561,236 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$1,558,000
3,339,156 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
15,014,401
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
0
Q4 2022 holders
30
Holder diff
30
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend